- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02892214
The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia
The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia, and the Mental Health of the Patient
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Provoked vestibulodynia (PVD) is the term describing a syndrome of provoked, localized allodynia of the vestibule of the vulva, not explained by another condition, and lasting more than 3 months. PVD is not a defined disease but rather a symptom. It is thought that PVD represent a group of distinct disorders that have been classified together because they produce pain in the same anatomic location.
Studies found that different factors such as genetic, inflammation, recurrent vaginitis, allergy, trauma, emotional and neural may be involved in the development of PVD.
Treatment of PVD is generally predicated on a trial and error basis, because the pathogenesis is not defined. The result is that many forms of therapeutic interventions have been used, yet the evidence remains largely inconclusive, the response rates varies considerably, and many women do not respond to any of the treatments. It is therefore important to recognize which factors mediate the syndrome's severity, and influence the effectiveness of treatments.
The proposed study will evaluate how different patients' characteristics (personality, cognitive) and responses (emotional and behavioral) influence the natural history of the syndrome and the response to treatment. The study is based on the bio-psycho-social model and the adult attachment theory, which integrates psychosocial factors to define susceptibility to acquire pain disorders and predict response to therapy. According to this model, choosing effective coping strategy during a crisis and receiving support from a spouse are vital for recovery.
The study aim to:
- Characterize interactions between attachment patterns, personality types, cognitive factors (catastrophization, coherence, and partner's support), emotional factors (coping strategies, emotional stress and satisfaction from intimate relationship) to pain levels, pelvic floor hypertonicity, sexual function and patient's emotional health.
- Examine whether treatments' results are influenced by personality, relationship, cognitive, emotional and behavioral characteristics of the patient.
- Recognize factors that influence the extent of adherence to treatment.
- Characterize patients' profile in regard to successful outcome.
Methods Patients will be recruited from the clinic for vulvovaginal disorders in Clalit Healthcare services in Jerusalem. The diagnostic procedures, patients' sub-classification and the proposed treatments in the current protocol are identical to those currently used in the clinic. Each patient will undergo a standard evaluation which includes: detailed history intake, vulvar and vaginal examination, evaluation of vestibular tenderness (Q tip test), pelvic floor musculature tenderness examination, vaginal pH measurement, saline and 10% potassium hydroxide microscopy, yeast and bacterial cultures and STD screening.
Patients who fulfill diagnostic criteria of PVD and who will be willing to participate in the study will be asked to sign an informed consent and complete the following self-administered intake questionnaires:
- Socio-demographic questionnaire (age, marital status, religios, PVD onset, health status, education etc.)
- Close Relations Experiences questionnaire
- Five Factor Inventory -NEO-FFI
- Pain catastrophizing questionnaire
- Sense of Coherence Scale
- Ways of giving support questionnaire
- COPE -Multidimensional Coping Inventory
- Semantic Differential Measure of Marital Satisfaction
- PSS-10 - Perceived Stress Scale
- FSFI-Female Sexual Function Index
Instructions for treatment will be given in regards to the diagnosis. Patients will be instructed to schedule follow-up appointments at 3,6,9, and 12 months. During follow-up appointments they will be assessed in regard to vestibular tenderness (using various parameters), as well as by the same questionnaires. Additional treatment will be recommended according to medical status, in an identical way to this routinely used in the clinic.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel
- Merkaz Briot Haisha, Ramat Eshkol
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- A history of 3 months or more of vulvar pain suggestive of PVD, i.e. symptoms of pain on vaginal penetration (insertional dyspareunia and/or pain with tampon insertion).
- On exam, tenderness localized within the vestibule when being touched with a cotton-tip applicator.
- No identifiable cause for the pain, such as vulvovaginal candidiasis, vaginal atrophy, desquamative inflammatory vaginitis (DIV), herpes, dermatitis or vulvar dystrophy.
Exclusion Criteria:
- other causes for vulvar pain
- pregnancy or a planned pregnancy in the upcoming year
- diagnosis of chronic disease that may affect central nervous system or general function.
- usage of psychiatric medications or those affecting pain modulation.
- unprovoked or mixed vulvodynia
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Hypertonic pelvic muscle dysfunction
In this subgroup, pelvic floor (PF) muscles become tight and tender.
Typically, the pain is much worse at 4-8 o'clock position of the vestibule with minimal or no pain in the upper vestibule.
|
|
Hormonally mediated PVD
The pain began while taking hormonal contraceptive or other medications that affect hormones, after removal of ovaries, breastfeeding or menopause.
The entire vestibule is tender and vestibular mucosa is often dry and thin.
|
|
Neuroproliferative PVD
In this condition, we speculate that women have an increased number of nociceptors in the vestibular mucosa.
Pain is primary and there is tenderness of the entire vestibule.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of measure of Q tip test assessing pain intensity
Time Frame: Change in measure between recruitment to 3 months, 6 months , 9 months and 12 months
|
The exam is performed by touching the vestibule with a cotton-tip applicator in 6 defined points (2,5,6,7, 10 and 12),while the patient is being asked to rate the intensity of pain verbally from 0 to 10 at each point.
|
Change in measure between recruitment to 3 months, 6 months , 9 months and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of vestibular tenderness using a vulvar algesiometer
Time Frame: Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
|
Change of pain using Visual analog scale
Time Frame: Change in VAS between recruitment to 3 months, 6 months , 9 months and 12 months
|
Change in VAS between recruitment to 3 months, 6 months , 9 months and 12 months
|
|
Adherence to therapy
Time Frame: Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Adherence to therapy will be assessed by calculating attendance to planed appointments (physical therapy, medical appointments and LLL treatments)
|
Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Female sexual function index questionnaire
Time Frame: Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
|
Pelvic floor hypertonicity measurements
Time Frame: Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Pelvic floor muscle tonicity will be evaluated using manual palpation of the muscles by the physician.
|
Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Brief Symptom Inventory-18 questionnaire (evaluating emotional symptoms)
Time Frame: Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Every 3 months for 1 year- 0, 3 months, 6 months, 9 months and 12 months.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989 Feb;56(2):267-83. doi: 10.1037//0022-3514.56.2.267.
- Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, Amsel R. A randomized comparison of group cognitive--behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001 Apr;91(3):297-306. doi: 10.1016/S0304-3959(00)00449-8.
- Andrews JC. Vulvodynia interventions--systematic review and evidence grading. Obstet Gynecol Surv. 2011 May;66(5):299-315. doi: 10.1097/OGX.0b013e3182277fb7.
- Antonovsky, A. (1987). How people manage stress and stay well. San Francisco, CA, US: Jossey-Bass Unraveling the mystery of health.
- Bergeron S, Brown C, Lord MJ, Oala M, Binik YM, Khalife S. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther. 2002 May-Jun;28(3):183-92. doi: 10.1080/009262302760328226.
- Brennan, K.A., Clark, C.L., & Shaver P.R. (1998). Self-report measurement of adult attachment: An integrative overview. In J.A. Simpson & W.S. Rholes (Eds.), Attachment theory and close relationships, (pp. 46-76). NY,US: Guilford Press.
- Buunk, B. P., Berkhuysen, M. A., Sanderman, R., Nieuwland, W., & Ranchor, A. V. (1996). Active engagement, protective buffering and overprotection: Instruments to measure the role of the spouse in heart rehabilitation. Gedrag & Gezondheid, 24, 304- 113.
- Cohen, S., & Spacapan, S. (1978). The aftereffects of stress: An attentional interpretation. Environmental Psychology and Nonverbal Behavior, 3(1), 43-57.
- Meredith P, Ownsworth T, Strong J. A review of the evidence linking adult attachment theory and chronic pain: presenting a conceptual model. Clin Psychol Rev. 2008 Mar;28(3):407-29. doi: 10.1016/j.cpr.2007.07.009. Epub 2007 Jul 19.
- Sadownik LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med. 2000 Aug;45(8):679-84.
- Sullivan, M. J. L., Bishop, S., & Pivic, J. (1995). The pain catastrophizing scale: Development and validation. Psychological Assessment, 7, 524-532.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0089-16-COM1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Localized Provoked Vulvodynia
-
University Hospital, GhentCompletedLocalized Provoked VulvodyniaBelgium
-
Oregon College of Oriental MedicineOregon Health and Science University; National Vulvodynia Association; Council...CompletedVulvodynia | Vulvar Vestibulitis | Provoked Vestibulodynia | Provoked, Localized VulvodyniaUnited States
-
Oregon Health and Science UniversityMedical Research Foundation, OregonCompleted
-
Meir Medical CenterCompleted
-
Oregon Health and Science UniversityEnrolling by invitation
-
Uppsala UniversityCompletedVulvodynia, Generalized | Provoked VestibulodyniaSweden
-
Oslo Metropolitan UniversityOslo University HospitalCompletedProvoked VestibulodyniaNorway
-
Université de SherbrookeCentre de recherche du Centre hospitalier universitaire de SherbrookeCompleted
-
Hadassah Medical OrganizationTerminatedProvoked VestibulodyniaIsrael
-
University of British ColumbiaCompletedVulvodynia | Provoked Vulvar VestibulodyniaCanada
Clinical Trials on Pelvic floor physical therapy
-
Boston Urogynecology AssociatesUnknownObstetric; Injury Pelvic Floor | Obstetrical LacerationsUnited States
-
University of California, IrvineEnrolling by invitationProstatic Hyperplasia | Stress Urinary IncontinenceUnited States
-
Orlando VA Medical CenterRecruitingPelvic Pain | Levator Ani Syndrome | Chronic Pelvic Pain Syndrome | Spastic Pelvic Floor Syndrome | Myalgia of Pelvic FloorUnited States
-
The Cleveland ClinicRecruitingLower Urinary Tract Symptoms | Urinary Retention | Benign Prostatic Hyperplasia With Outflow ObstructionUnited States
-
University of California, San FranciscoNational Multiple Sclerosis SocietyRecruitingMultiple Sclerosis | Urinary Bladder, OveractiveUnited States
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingInterstitial Cystitis | Cystitis, Interstitial | Painful Bladder Syndrome | Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Bladder Pain Syndrome | Chronic Interstitial Cystitis | Interstitial Cystitis, Chronic | Cystitis, Chronic Interstitial | Interstitial Cystitis (Chronic)... and other conditions
-
PelexRecruitingStress Urinary Incontinence | Pelvic Floor DisordersUnited States
-
The Cleveland ClinicCompletedPelvic Floor DisordersUnited States
-
Queen's UniversityOttawa Hospital Research InstituteCompletedStress Urinary IncontinenceCanada
-
Hasan Kalyoncu UniversityRecruitingUrinary Incontinence | Urinary Tract DisordersTurkey